Zim Laboratories Ltd (NSE:ZIMLAB)
₹ 124.9 -2.97 (-2.32%) Market Cap: 6.63 Bil Enterprise Value: 7.62 Bil PE Ratio: 104.98 PB Ratio: 2.26 GF Score: 76/100

Q1 2026 ZIM Laboratories Ltd Earnings Call Transcript

Aug 12, 2025 / 06:30 AM GMT
Release Date Price: ₹76.88 (+0.96%)

Key Points

Positve
  • Zim Laboratories Ltd (BOM:541400) reported a significant increase in net profit, rising by 107.78% year-over-year.
  • The company achieved a 111.11% increase in EPS, indicating improved profitability per share.
  • Despite challenges, the Indian business recorded robust growth of 30.2% year-over-year.
  • The company has a strong development pipeline with two NIP products in progress and 88 filings in the EU.
  • Zim Laboratories Ltd (BOM:541400) is actively engaging external experts to address EU GMP inspection observations, showing commitment to compliance and quality improvement.
Negative
  • The company experienced a 12.3% decline in total operating income year-over-year, primarily due to disruptions in the Middle East.
  • Operating profit decreased by 47.14% year-over-year, reflecting challenges in maintaining profitability.
  • The EU GMP inspection resulted in two critical and several major observations, potentially delaying product launches in the EU.
  • There was a significant decline in the contribution of innovative products to the topline, impacting overall revenue.
  • The geopolitical instability in key markets, particularly in the Middle East, has led to supply challenges and revenue declines.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ZIML.NS - Zim Laboratories Ltd
Q1 2026 ZIM Laboratories Ltd Earnings Call
Aug 12, 2025 / 06:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
For financial summary, stay here. For full earnings call recording, skip to minute 2.

ZIMLAB financial results for June 2025 quarter with YOY comparison.

Revenue, â¹71.76 crore versus â¹81.82 crore YOY with a change of minus 12.30%. Expenses, â¹67.51 crore versus â¹73.78 crore YOY with a change of minus 8.50%. Other income, â¹1.48 crore versus â¹1 crore YOY with a change of plus 48.00%. Profit before tax, â¹2.43 crore versus â¹1.24 crore YOY with a change of plus 95.97%. Net profit, â¹1.87 crore versus â¹0.90 crore YOY with a change of 107.78%. EPS 38 peso versus â¹0 0. 18 YOY with a change of 111.11%. Operating profit, â¹4.25 crore versus â¹8.04 crore YOY with a change of minus 47.14%.

--------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot